Hallucinogens

CHAPTER 12 - Hallucinogens

12.1 Overview of Hallucinogens

  • Definition: Hallucinogens are drugs that alter sensory perception, mood, and cognition. They create profound effects on consciousness, often leading to altered states of awareness.

  • Historical Terms:

    • Initially termed psychomimetics due to a belief they mimicked symptoms of psychosis (e.g., schizophrenia).

    • The term psychedelic was popularized by Humphry Osmond in the 1960s, defined as 'mind-expanding or mind-revealing.' However, this term is deemed controversial.

    • The modern term used is hallucinogen, despite it being somewhat misleading as not all hallucinogens produce hallucinations (e.g., methylated amphetamines).

  • Complexity: There are over 90 different species of plants and numerous synthetic compounds that can produce hallucinogenic effects. They can alter nearly all aspects of psychological functioning and lead to various alterations in consciousness.

12.2 Types of Hallucinogens

Classification of Hallucinogens

  • Hallucinogens can be classified based on their mechanism and effects into five different groups:

    • Serotonergic Hallucinogens

    • Methylated Amphetamines

    • Anticholinergic Hallucinogens

    • Dissociative Anesthetic Hallucinogens

    • Salvinorin A (Salvia)

12.2.1 Serotonergic Hallucinogens

  • Representatives: LSD (lysergic acid diethylamide), psilocybin (from mushrooms), mescaline (from peyote cactus).

  • Mechanism of Action: These drugs primarily affect serotonin transmission in the brain, binding to a subtype of serotonin receptor known as 5-HT2A receptors, crucial for producing visual hallucinations.

  • Effects: Vivid visual hallucinations and other alterations of consciousness.

12.2.2 Methylated Amphetamines

  • Examples: MDMA (Ecstasy), MDA.

  • Characteristics: Although related to amphetamines, they're noted for unique effects on emotionality, social behavior, and empathy, enhancing mood without significant sensory disturbance. They act on dopamine, norepinephrine, and serotonin synapses.

  • Psychoactive Properties: Often referred to as entactogens or empathogens due to their effects of increased emotional warmth and sociability.

12.2.3 Anticholinergic Hallucinogens

  • Examples: Atropine and scopolamine from plants like belladonna, henbane, mandrake, and jimsonweed.

  • Mechanism of Action: These drugs block muscarinic acetylcholine receptors, resulting in a trance-like state with little memory of the experience.

12.2.4 Dissociative Anesthetic Hallucinogens

  • Examples: PCP (phencyclidine) and ketamine.

  • Mechanism of Action: They block NMDA receptors for glutamate, resulting in dissociation while potentially leaving the individual semiconscious. Their effects can include euphoria, numbness, and distorted perceptions.

12.2.5 Salvinorin A

  • Source: Salvia divinorum, often used in rituals by the Mazatec people.

  • Mechanism: Acts primarily as an agonist at kappa opioid receptors, with effects that include intense visions and sensory disturbances.

12.3 Historical and Cultural Context

Early Use of Hallucinogens

  • Historical accounts of hallucinogen use by indigenous peoples, especially in Central and South America, include:

    • Peyote and psilocybin mushrooms were used by Aztecs for religious and healing purposes, regarded as sacred and described as providing oracles for decision-making.

    • Ayahuasca: Derived from multiple plant sources containing DMT, traditionally used in spiritual healing ceremonies.

  • Reintroduction: Hallucinogen use experienced a significant cultural impact in the 1960s, primarily with the introduction of LSD in psychotherapy and countercultural movements.

12.4 Mechanisms and Effects of LSD

Mechanisms of Action

  • LSD and similar hallucinogens act on serotonin receptors, predominantly 5-HT2A. Key evidence points towards activity changes in brain systems mediated by serotonin.

  • Pharmacokinetics: LSD is highly potent, with effective oral doses as low as 25 micrograms; its effects last between 8-12 hours.

Effects on Psychology

  • Physiological Effects: Common effects include increased heart rate, pupil dilation, and sympathomimetic symptoms akin to stimulant drugs.

  • Psychological Effects: Variability among experiences includes visual distortions, changes in mood, and experiences of synesthesia (e.g., seeing sounds). Hallucinogenic trips can vary from euphoria to panic or paranoia.

Adverse Effects

  • Concerns about long-term consequences include panic reactions, flashbacks, and psychological disorders. Research indicates safety in moderate settings, but adverse reactions still warrant clinical caution.

12.5 Clinical Applications of Hallucinogens

Psychotherapy

  • Potential therapeutic applications of serotonergic hallucinogens have surfaced again due to promising results in treating conditions like depression, PTSD, and anxiety. Research on MDMA, psilocybin, and ketamine in controlled settings shows some positive therapeutic outcomes.

  • Research Challenges: Studies must navigate the dual nature of placebos and effects, as well as ensure safe doubled-blind methodologies due to the known subjective effects of hallucinogens.

Current Research Trends

  • Renewed interest in the psychotherapeutic potential of psilocybin and MDMA is observed, with various studies indicating beneficial insights and reductions in distress among participants.

12.6 Methylated Amphetamines and MDMA

Overview

  • Popularity: MDMA transitioned from therapeutic potential to club drug fame, spreading rapidly through rave culture in the 1990s. Despite a decline in use, interest resurfaces on MDMA as a therapeutic agent due to its empathogenic qualities.

Physiological Effects and Risks

  • Users often report feelings of warmth, euphoria, and trust. However, the risks of dehydration, heatstroke, and toxic reactions increase with dose escalation.

Long-term Effects on Brain Structure

  • Evidence for neurotoxicity exists but is subject to intense debate based on varying drug purity and polydrug use patterns. Studies suggest potential recovery of serotonergic systems following abstinence.

Clinical Potential

  • Early findings indicate potential efficacy in therapy settings for PTSD and depression, leading to ongoing research initiatives and clinical testing.

12.7 Anticholinergic and Dissociative Anesthetic Hallucinogens

Anticholinergics

  • Atropine and scopolamine exhibit sedation coupled with confusion and hallucinations, often associated with historical witchcraft. These effects can be dangerous, leading to respiratory failure under inadequate dosage monitoring.

Dissociative Anesthetics

  • PCP: Initially an anesthetic, now mostly seen as a recreational drug with potential for severe side effects, including prolonged psychotic states.

  • Ketamine: Gaining a foothold in treatment-resistant depression interventions, evaluated for rapid-acting antidepressant properties, emphasizing its growing role in modern psychological therapy.

12.8 Salvinorin A - Salvia

  • Effects: Salvia produces intense hallucinations but its effects are short-lived, with mechanisms distinct from other hallucinogens, primarily acting on kappa receptors.

  • Popularity: While previously illegal, it is currently a subject of increasing interest; potential future regulation is under consideration.

Summary

  • Hallucinogens affect perception, cognition, and emotional experiences, categorized into five classes, each with unique effects, mechanisms, and histories. Research into their therapeutic applications is resurging, highlighting potential benefits amidst ongoing discussions about safety and long-term effects.

Key Terms

  • Anticholinergic Hallucinogens: Drugs that block acetylcholine in the brain.

  • Dissociative Anesthetic: A class of drugs creating dissociation from sensory awareness.

  • Flashback: A re-experience of a drug-induced state.

  • Ketamine: A dissociative anesthetic used in clinical settings.

  • Mescaline: A naturally occurring psychedelic found in peyote.

  • Methylated Amphetamines: Drugs with structural similarities to amphetamines with unique effects.

12.1 Overview of Hallucinogens

  • Definition: Hallucinogens are drugs that alter sensory perception, mood, and cognition. They create profound effects on consciousness, often leading to altered states of awareness.

  • Historical Terms: - Initially termed psychomimetics due to a belief they mimicked symptoms of psychosis (e.g., schizophrenia).

    • The term psychedelic was popularized by Humphry Osmond in the 1960s, defined as 'mind-expanding or mind-revealing.' However, this term is deemed controversial.

    • The modern term used is hallucinogen, despite it being somewhat misleading as not all hallucinogens produce hallucinations (e.g., methylated amphetamines).

  • Complexity: There are over 90 different species of plants and numerous synthetic compounds that can produce hallucinogenic effects. They can alter nearly all aspects of psychological functioning and lead to various alterations in consciousness.

12.2 Types of Hallucinogens

Classification of Hallucinogens

  • Hallucinogens can be classified based on their mechanism and effects into five different groups:- Serotonergic Hallucinogens

    • Methylated Amphetamines

    • Anticholinergic Hallucinogens

    • Dissociative Anesthetic Hallucinogens

    • Salvinorin A (Salvia)

12.2.1 Serotonergic Hallucinogens

  • Representatives: LSD (lysergic acid diethylamide), psilocybin (from mushrooms), mescaline (from peyote cactus).

  • Mechanism of Action: These drugs primarily affect serotonin transmission in the brain, binding to a subtype of serotonin receptor known as 5-HT2A receptors, crucial for producing visual hallucinations.

  • Effects: Vivid visual hallucinations and other alterations of consciousness.

12.2.2 Methylated Amphetamines

  • Examples: MDMA (Ecstasy), MDA.

  • Characteristics: Although related to amphetamines, they're noted for unique effects on emotionality, social behavior, and empathy, enhancing mood without significant sensory disturbance. They act on dopamine, norepinephrine, and serotonin synapses.

  • Psychoactive Properties: Often referred to as entactogens or empathogens due to their effects of increased emotional warmth and sociability.

12.2.3 Anticholinergic Hallucinogens

  • Examples: Atropine and scopolamine from plants like belladonna, henbane, mandrake, and jimsonweed.

  • Mechanism of Action: These drugs block muscarinic acetylcholine receptors, resulting in a trance-like state with little memory of the experience.

12.2.4 Dissociative Anesthetic Hallucinogens

  • Examples: PCP (phencyclidine) and ketamine.

  • Mechanism of Action: They block NMDA receptors for glutamate, resulting in dissociation while potentially leaving the individual semiconscious. Their effects can include euphoria, numbness, and distorted perceptions.

12.2.5 Salvinorin A

  • Source: Salvia divinorum, often used in rituals by the Mazatec people.

  • Mechanism: Acts primarily as an agonist at kappa opioid receptors, with effects that include intense visions and sensory disturbances.

12.3 Historical and Cultural Context

Early Use of Hallucinogens

  • Historical accounts of hallucinogen use by indigenous peoples, especially in Central and South America, include:- Peyote and psilocybin mushrooms were used by Aztecs for religious and healing purposes, regarded as sacred and described as providing oracles for decision-making.

    • Ayahuasca: Derived from multiple plant sources containing DMT, traditionally used in spiritual healing ceremonies.

  • Reintroduction: Hallucinogen use experienced a significant cultural impact in the 1960s, primarily with the introduction of LSD in psychotherapy and countercultural movements.

12.4 Mechanisms and Effects of LSD

Mechanisms of Action

  • LSD and similar hallucinogens act on serotonin receptors, predominantly 5-HT2A. Key evidence points towards activity changes in brain systems mediated by serotonin.

  • Pharmacokinetics: LSD is highly potent, with effective oral doses as low as 25 micrograms; its effects last between 8-12 hours.

Effects on Psychology

  • Physiological Effects: Common effects include increased heart rate, pupil dilation, and sympathomimetic symptoms akin to stimulant drugs.

  • Psychological Effects: Variability among experiences includes visual distortions, changes in mood, and experiences of synesthesia (e.g., seeing sounds). Hallucinogenic trips can vary from euphoria to panic or paranoia.

Adverse Effects

  • Concerns about long-term consequences include panic reactions, flashbacks, and psychological disorders. Research indicates safety in moderate settings, but adverse reactions still warrant clinical caution.

12.5 Clinical Applications of Hallucinogens

Psychotherapy

  • Potential therapeutic applications of serotonergic hallucinogens have surfaced again due to promising results in treating conditions like depression, PTSD, and anxiety. Research on MDMA, psilocybin, and ketamine in controlled settings shows some positive therapeutic outcomes.

  • Research Challenges: Studies must navigate the dual nature of placebos and effects, as well as ensure safe doubled-blind methodologies due to the known subjective effects of hallucinogens.

Current Research Trends

  • Renewed interest in the psychotherapeutic potential of psilocybin and MDMA is observed, with various studies indicating beneficial insights and reductions in distress among participants.

12.6 Methylated Amphetamines and MDMA

Overview

  • Popularity: MDMA transitioned from therapeutic potential to club drug fame, spreading rapidly through rave culture in the 1990s. Despite a decline in use, interest resurfaces on MDMA as a therapeutic agent due to its empathogenic qualities.

Physiological Effects and Risks

  • Users often report feelings of warmth, euphoria, and trust. However, the risks of dehydration, heatstroke, and toxic reactions increase with dose escalation.

Long-term Effects on Brain Structure

  • Evidence for neurotoxicity exists but is subject to intense debate based on varying drug purity and polydrug use patterns. Studies suggest potential recovery of serotonergic systems following abstinence.

Clinical Potential

  • Early findings indicate potential efficacy in therapy settings for PTSD and depression, leading to ongoing research initiatives and clinical testing.

12.7 Anticholinergic and Dissociative Anesthetic Hallucinogens

Anticholinergics

  • Atropine and scopolamine exhibit sedation coupled with confusion and hallucinations, often associated with historical witchcraft. These effects can be dangerous, leading to respiratory failure under inadequate dosage monitoring.

Dissociative Anesthetics

  • PCP: Initially an anesthetic, now mostly seen as a recreational drug with potential for severe side effects, including prolonged psychotic states.

  • Ketamine: Gaining a foothold in treatment-resistant depression interventions, evaluated for rapid-acting antidepressant properties, emphasizing its growing role in modern psychological therapy.

12.8 Salvinorin A - Salvia

  • Effects: Salvia produces intense hallucinations but its effects are short-lived, with mechanisms distinct from other hallucinogens, primarily acting on kappa receptors.

  • Popularity: While previously illegal, it is currently a subject of increasing interest; potential future regulation is under consideration.

Summary

  • Hallucinogens affect perception, cognition, and emotional experiences, categorized into five classes, each with unique effects, mechanisms, and histories. Research into their therapeutic applications is resurging, highlighting potential benefits amidst ongoing discussions about safety and long-term effects.

Key Terms

  • Anticholinergic Hallucinogens: Drugs that block acetylcholine in the brain.

  • Dissociative Anesthetic: A class of drugs creating dissociation from sensory awareness.

  • Flashback: A re-experience of a drug-induced state.

  • Ketamine: A dissociative anesthetic used in clinical settings.

  • Mescaline: A naturally occurring psychedelic found in peyote.

  • Methylated Amphetamines: Drugs with structural similarities to amphetamines with unique effects.

CHAPTER 12 - Hallucinogens

12.1 Overview of Hallucinogens

  • Definition: Hallucinogens are drugs that alter sensory perception, mood, and cognition. They create profound effects on consciousness, often leading to altered states of awareness.

  • Historical Terms:

    • Initially termed psychomimetics due to a belief they mimicked symptoms of psychosis (e.g., schizophrenia).

    • The term psychedelic was popularized by Humphry Osmond in the 1960s, defined as 'mind-expanding or mind-revealing.' However, this term is deemed controversial.

    • The modern term used is hallucinogen, despite it being somewhat misleading as not all hallucinogens produce hallucinations (e.g., methylated amphetamines).

  • Complexity: There are over 90 different species of plants and numerous synthetic compounds that can produce hallucinogenic effects. They can alter nearly all aspects of psychological functioning and lead to various alterations in consciousness.

12.2 Types of Hallucinogens

Classification of Hallucinogens

  • Hallucinogens can be classified based on their mechanism and effects into five different groups:

    • Serotonergic Hallucinogens

    • Methylated Amphetamines

    • Anticholinergic Hallucinogens

    • Dissociative Anesthetic Hallucinogens

    • Salvinorin A (Salvia)

12.2.1 Serotonergic Hallucinogens

  • Representatives: LSD (lysergic acid diethylamide), psilocybin (from mushrooms), mescaline (from peyote cactus).

  • Mechanism of Action: These drugs primarily affect serotonin transmission in the brain, binding to a subtype of serotonin receptor known as 5-HT2A receptors, crucial for producing visual hallucinations.

  • Effects: Vivid visual hallucinations and other alterations of consciousness.

12.2.2 Methylated Amphetamines

  • Examples: MDMA (Ecstasy), MDA.

  • Characteristics: Although related to amphetamines, they're noted for unique effects on emotionality, social behavior, and empathy, enhancing mood without significant sensory disturbance. They act on dopamine, norepinephrine, and serotonin synapses.

  • Psychoactive Properties: Often referred to as entactogens or empathogens due to their effects of increased emotional warmth and sociability.

12.2.3 Anticholinergic Hallucinogens

  • Examples: Atropine and scopolamine from plants like belladonna, henbane, mandrake, and jimsonweed.

  • Mechanism of Action: These drugs block muscarinic acetylcholine receptors, resulting in a trance-like state with little memory of the experience.

12.2.4 Dissociative Anesthetic Hallucinogens

  • Examples: PCP (phencyclidine) and ketamine.

  • Mechanism of Action: They block NMDA receptors for glutamate, resulting in dissociation while potentially leaving the individual semiconscious. Their effects can include euphoria, numbness, and distorted perceptions.

12.2.5 Salvinorin A

  • Source: Salvia divinorum, often used in rituals by the Mazatec people.

  • Mechanism: Acts primarily as an agonist at kappa opioid receptors, with effects that include intense visions and sensory disturbances.

12.3 Historical and Cultural Context

Early Use of Hallucinogens

  • Historical accounts of hallucinogen use by indigenous peoples, especially in Central and South America, include:

    • Peyote and psilocybin mushrooms, also known as teonanacatl ('flesh of the gods'), were used by Aztecs for religious and healing purposes, regarded as sacred and described as providing oracles for decision-making.

    • Ayahuasca: Derived from multiple plant sources containing DMT, traditionally used in spiritual healing ceremonies.

  • Reintroduction: Hallucinogen use experienced a significant cultural impact in the 1960s, primarily with the introduction of LSD in psychotherapy and countercultural movements.

12.4 Mechanisms and Effects of LSD

Mechanisms of Action

  • LSD and similar hallucinogens act on serotonin receptors, predominantly 5-HT2A. Key evidence points towards activity changes in brain systems mediated by serotonin.

  • Pharmacokinetics: LSD is highly potent, with effective oral doses as low as 25 micrograms; its effects last between 8-12 hours.

Effects on Psychology

  • Physiological Effects: Common effects include increased heart rate, pupil dilation, and sympathomimetic symptoms akin to stimulant drugs.

  • Psychological Effects: Variability among experiences includes visual distortions, changes in mood, and experiences of synesthesia (e.g., seeing sounds). Hallucinogenic trips can vary from euphoria to panic or paranoia.

Adverse Effects

  • Concerns about long-term consequences include panic reactions, flashbacks, and psychological disorders. Research indicates safety in moderate settings, but adverse reactions still warrant clinical caution.

12.5 Clinical Applications of Hallucinogens

Psychotherapy

  • Potential therapeutic applications of serotonergic hallucinogens have surfaced again due to promising results in treating conditions like depression, PTSD, and anxiety. Research on MDMA, psilocybin, and ketamine in controlled settings shows some positive therapeutic outcomes.

  • Research Challenges: Studies must navigate the dual nature of placebos and effects, as well as ensure safe doubled-blind methodologies due to the known subjective effects of hallucinogens.

Current Research Trends

  • Renewed interest in the psychotherapeutic potential of psilocybin and MDMA is observed, with various studies indicating beneficial insights and reductions in distress among participants.

12.6 Methylated Amphetamines and MDMA

Overview

  • Popularity: MDMA transitioned from therapeutic potential to club drug fame, spreading rapidly through rave culture in the 1990s. Despite a decline in use, interest resurfaces on MDMA as a therapeutic agent due to its empathogenic qualities.

Physiological Effects and Risks

  • Users often report feelings of warmth, euphoria, and trust. However, the risks of dehydration, heatstroke, and toxic reactions increase with dose escalation.

Long-term Effects on Brain Structure

  • Evidence for neurotoxicity exists but is subject to intense debate based on varying drug purity and polydrug use patterns. Studies suggest potential recovery of serotonergic systems following abstinence.

Clinical Potential

  • Early findings indicate potential efficacy in therapy settings for PTSD and depression, leading to ongoing research initiatives and clinical testing.

12.7 Anticholinergic and Dissociative Anesthetic Hallucinogens

Anticholinergics

  • Atropine and scopolamine exhibit sedation coupled with confusion and hallucinations, often associated with historical witchcraft. These effects can be dangerous, leading to respiratory failure under inadequate dosage monitoring.

Dissociative Anesthetics

  • PCP: Initially an anesthetic, now mostly seen as a recreational drug with potential for severe side effects, including prolonged psychotic states.

  • Ketamine: Gaining a foothold in treatment-resistant depression interventions, evaluated for rapid-acting antidepressant properties, emphasizing its growing role in modern psychological therapy.

12.8 Salvinorin A - Salvia

  • Effects: Salvia produces intense hallucinations but its effects are short-lived, with mechanisms distinct from other hallucinogens, primarily acting on kappa receptors.

  • Popularity: While previously illegal, it is currently a subject of increasing interest; potential future regulation is under consideration.

Summary

  • Hallucinogens affect perception, cognition, and emotional experiences, categorized into five classes, each with unique effects, mechanisms, and histories. Research into their therapeutic applications is resurging, highlighting potential benefits amidst ongoing discussions about safety and long-term effects.

Key Terms

  • Anticholinergic Hallucinogens: Drugs that block acetylcholine in the brain.

  • Dissociative Anesthetic: A class of drugs creating dissociation from sensory awareness.

  • Flashback: A re-experience of a drug-induced state.

  • Ketamine: A dissociative anesthetic used in clinical settings.

  • Mescaline: A naturally occurring psychedelic found in peyote.

  • Methylated Amphetamines: Drugs with structural similarities to amphetamines with unique effects.

12.4 Mechanisms and Effects of LSD

Mechanisms of Action

  • LSD and similar hallucinogens act on serotonin receptors, predominantly 5-HT2A. Key evidence points towards activity changes in brain systems mediated by serotonin.

  • Pharmacokinetics: LSD is highly potent, with effective oral doses as low as 25 micrograms; its effects last between 8-12 hours.

12.2 Types of Hallucinogens

12.2.1 Serotonergic Hallucinogens

  • Mechanism of Action: These drugs primarily affect serotonin transmission in the brain, binding to a subtype of serotonin receptor known as 5-HT2A receptors, crucial for producing visual hallucinations.

12.2.2 Methylated Amphetamines

  • Mechanism of Action: They act on dopamine, norepinephrine, and serotonin synapses.

12.2.3 Anticholinergic Hallucinogens

  • Mechanism of Action: These drugs block muscarinic acetylcholine receptors, resulting in a trance-like state with little memory of the experience.

12.2.4 Dissociative Anesthetic Hallucinogens

  • Mechanism of Action: They block NMDA receptors for glutamate, resulting in dissociation while potentially leaving the individual semiconscious.

12.2.5 Salvinorin A

  • Mechanism: Acts primarily as an agonist at kappa opioid receptors, with effects that include intense visions and sensory disturbances.